A randomized trial comparing bladder volume consistency during fractionated prostate radiation therapy
dc.contributor.author | Mullaney, L. | |
dc.contributor.author | O'Shea, E. | |
dc.contributor.author | Dunne, M. | |
dc.contributor.author | Finn, M. | |
dc.contributor.author | Thirion, P. | |
dc.contributor.author | Cleary, L. A. | |
dc.contributor.author | McGarry, M. | |
dc.contributor.author | O'Neill, L. | |
dc.contributor.author | Armstrong, J.G. | |
dc.date.accessioned | 2014-08-15T08:45:30Z | |
dc.date.available | 2014-08-15T08:45:30Z | |
dc.date.issued | 2014-01-10 | |
dc.identifier.citation | Mullaney L et al. A randomized trial comparing bladder volume consistency during fractionated prostate radiation therapy. Pract Rad Oncol. Jan 10 2014 [published online] | en_GB |
dc.identifier.doi | http://dx.doi.org/10.1016/j.prro.2013.11.006 | |
dc.identifier.uri | http://hdl.handle.net/10147/324811 | |
dc.description.abstract | Organ motion is a contributory factor to the variation in location of the prostate and organs at risk during a course of fractionated prostate radiation therapy (RT). A prospective randomized controlled trial was designed with the primary endpoint to provide evidence-based bladder-filling instructions to achieve a consistent bladder volume (BV) and thus reduce the bladder-related organ motion. The secondary endpoints were to assess the incidence of acute and late genitourinary (GU) and gastrointestinal (GI) toxicity for patients and patients’ satisfaction with the bladder-filling instructions. | |
dc.language.iso | en | en |
dc.subject | PROSTATE CANCER | en_GB |
dc.subject.other | RADIATION THERAPY | en_GB |
dc.title | A randomized trial comparing bladder volume consistency during fractionated prostate radiation therapy | en_GB |
dc.type | Article | en |
dc.identifier.journal | Practical Radiation Oncology | en_GB |
dc.description.funding | No funding | en |
dc.description.province | Leinster | en |
dc.description.peer-review | peer-review | en |
html.description.abstract | Organ motion is a contributory factor to the variation in location of the prostate and organs at risk during a course of fractionated prostate radiation therapy (RT). A prospective randomized controlled trial was designed with the primary endpoint to provide evidence-based bladder-filling instructions to achieve a consistent bladder volume (BV) and thus reduce the bladder-related organ motion. The secondary endpoints were to assess the incidence of acute and late genitourinary (GU) and gastrointestinal (GI) toxicity for patients and patients’ satisfaction with the bladder-filling instructions. |